XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Interim Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Research and development $ (1,365) $ (2,193) $ (2,982) $ (3,899)
General and administrative (959) (1,370) (2,261) (2,840)
Operating loss (2,324) (3,563) (5,243) (6,379)
Financing income, net 37 50 103 37
Net loss $ (2,287) $ (3,513) $ (5,140) $ (6,702)
Basic net loss per share $ (0.25) $ (0.49) $ (0.60) $ (0.94)
Diluted net loss per share $ (0.25) $ (0.49) $ (0.60) $ (0.94)
Basic weighted average common shares outstanding 9,198,806 7,108,133 8,609,325 7,108,133
Diluted weighted average common shares outstanding 9,198,806 7,108,133 8,609,325 7,108,133